Kizoo Technology Capital

Reservoir Neuroscience, Inc. is a biopharmaceutical company focused on developing innovative therapeutics aimed at repairing the blood-brain barrier and restoring vascular function in the brain. Founded in 2019 and based in Emeryville, California, the company targets neurological disorders, including Alzheimer's disease, by addressing dysfunctional blood vessels in the brain. Its therapeutics are designed to improve cognitive function and enhance disease outcomes for patients suffering from age-related cognitive impairment and other neurological conditions.

Cellvie is a biotechnology company focused on developing cell-derived medicines that harness the therapeutic potential of mitochondria, the essential organelles responsible for energy production in cells. The company specializes in innovative techniques for the transplantation of viable mitochondria into compromised cells, aiming to restore their energy metabolism and function. This approach addresses mitochondrial dysfunction associated with various medical conditions, including heart disease, stroke, diabetes, Parkinson's, and Alzheimer's. By employing proprietary preparation and delivery methods, Cellvie seeks to interrupt the damaging cascade of events caused by ischemia-reperfusion injury, ultimately enhancing cellular performance and improving patient outcomes.

Mogling Bio is a biotechnology firm focused on developing innovative pharmacological approaches to rejuvenate aging stem cells, particularly within the hematopoietic system. The company's primary strategy involves inhibiting the elevated activity of Cdc42, a process that aims to restore the functionality of old stem cells. This rejuvenation has the potential to improve the production of blood and immune cells, providing new treatment options for patients suffering from leukemia and other blood disorders. By addressing the underlying causes of these conditions, Mogling Bio endeavors to strengthen patients' immune systems and enhance their overall health outcomes.

Elastrin Therapeutics is a biotechnology startup dedicated to improving health by restoring damaged and hardened tissues to their natural resilience. The company focuses on developing innovative therapeutics that target and reverse the calcification and hardening of arteries, as well as inflammatory tissue damage in conditions such as arterial and lung diseases. Elastrin's proprietary platform combines particle design with elastin targeting to enhance drug efficacy and eliminate side effects, aiming to provide effective treatments for life-threatening illnesses.

Revel Pharmaceuticals Inc. is a biotechnology company focused on developing therapeutic designer enzymes aimed at degrading molecular damage associated with aging. Incorporated in 2019 and based in San Francisco, California, the company’s lead product, GlycoSENS, specifically targets glucosepane crosslinks to help maintain and restore the elasticity of blood vessels, skin, and other tissues, thereby counteracting age-related stiffness. Revel's portfolio addresses various age-related diseases, including osteoarthritis, kidney disease, cardiovascular disease, skin aging, and complications related to diabetes. Through its proprietary enzyme discovery and engineering platform, the company seeks to provide innovative therapeutics that improve health outcomes for aging populations.

Underdog Pharmaceuticals, Inc. is a biotechnology company focused on developing regenerative medicine and direct interventions to address age-related diseases. Founded in 2019 and based in Mountain View, California, the company aims to target toxic forms of cholesterol with its innovative products. These treatments provide potential solutions for conditions such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. Underdog Pharmaceuticals utilizes rationally designed molecules and novel derivatives of established compounds to create disease-modifying therapies, reflecting a new perspective on cardiovascular health influenced by the SENS Research Foundation. Through its research and product development, the company seeks to treat the underlying causes of age-related diseases rather than merely addressing their symptoms.

Staffbase is a company that specializes in enhancing employee communication through its comprehensive Communications Cloud platform. The platform is designed for large and international organizations across various sectors, including manufacturing, healthcare, logistics, automotive, retail, and energy. It enables employers to securely engage with their workforce, ensuring that employees have easy access to relevant corporate information and digital workplace tools, including existing intranets. With a focus on mobile compatibility, Staffbase's solutions allow companies to effectively connect with their employees, regardless of their location, whether in the office, at home, or on the factory floor. Serving over 2,500 leading organizations worldwide, Staffbase is dedicated to transforming the way companies communicate with their employees.

Elastrin Therapeutics is a biotechnology startup dedicated to improving health by restoring damaged and hardened tissues to their natural resilience. The company focuses on developing innovative therapeutics that target and reverse the calcification and hardening of arteries, as well as inflammatory tissue damage in conditions such as arterial and lung diseases. Elastrin's proprietary platform combines particle design with elastin targeting to enhance drug efficacy and eliminate side effects, aiming to provide effective treatments for life-threatening illnesses.

Cellvie is a biotechnology company focused on developing cell-derived medicines that harness the therapeutic potential of mitochondria, the essential organelles responsible for energy production in cells. The company specializes in innovative techniques for the transplantation of viable mitochondria into compromised cells, aiming to restore their energy metabolism and function. This approach addresses mitochondrial dysfunction associated with various medical conditions, including heart disease, stroke, diabetes, Parkinson's, and Alzheimer's. By employing proprietary preparation and delivery methods, Cellvie seeks to interrupt the damaging cascade of events caused by ischemia-reperfusion injury, ultimately enhancing cellular performance and improving patient outcomes.

Elevian, Inc. is a biotechnology company based in Menlo Park, California, founded in 2017. The company specializes in developing regenerative medicines aimed at preventing and treating age-related diseases. Elevian focuses on therapeutics that regulate circulating factors, particularly Growth Differentiation Factor 11 (GDF11), which are known to stimulate the regeneration of various tissues, including those in the brain, heart, pancreas, and muscle. By targeting the underlying mechanisms of aging, Elevian aims to halt and potentially reverse the molecular damage associated with aging. Its research and development efforts are directed toward conditions such as stroke recovery, Alzheimer’s disease, coronary artery disease, and Type 2 diabetes.

Staffbase is a company that specializes in enhancing employee communication through its comprehensive Communications Cloud platform. The platform is designed for large and international organizations across various sectors, including manufacturing, healthcare, logistics, automotive, retail, and energy. It enables employers to securely engage with their workforce, ensuring that employees have easy access to relevant corporate information and digital workplace tools, including existing intranets. With a focus on mobile compatibility, Staffbase's solutions allow companies to effectively connect with their employees, regardless of their location, whether in the office, at home, or on the factory floor. Serving over 2,500 leading organizations worldwide, Staffbase is dedicated to transforming the way companies communicate with their employees.

Underdog Pharmaceuticals, Inc. is a biotechnology company focused on developing regenerative medicine and direct interventions to address age-related diseases. Founded in 2019 and based in Mountain View, California, the company aims to target toxic forms of cholesterol with its innovative products. These treatments provide potential solutions for conditions such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. Underdog Pharmaceuticals utilizes rationally designed molecules and novel derivatives of established compounds to create disease-modifying therapies, reflecting a new perspective on cardiovascular health influenced by the SENS Research Foundation. Through its research and product development, the company seeks to treat the underlying causes of age-related diseases rather than merely addressing their symptoms.

MAIA Biotechnology, Inc., established as a clinical-stage biopharmaceutical company, specializes in developing targeted immunotherapies for cancer patients. Its primary focus lies in creating first-in-class drugs with novel mechanisms of action to significantly enhance and prolong lives. MAIA's lead program, THIO, is a potential telomere-targeting agent currently in clinical development for treating telomerase-positive cancer cells.

LIfT BioSciences is a biotechnology company based in London, established in 2016, that specializes in advanced innate immuno-cell therapies. It has developed a unique platform known as Neutrophil Only Leukocyte Infusion Therapy (N-LIfT), which enables the production of Immunomodulatory Alpha Neutrophils (IMANs) from induced pluripotent stem cells (iPSCs). This technology aims to address the limitations of existing therapies for solid tumors by utilizing CAR neutrophil cell therapy. The IMANs can alter the tumor microenvironment, enhancing the immune response and enabling a more effective attack on tumors. By leveraging proprietary enhancement media and genetic engineering, LIfT BioSciences seeks to significantly increase the cancer-fighting capabilities of these cells, offering patients the potential for improved outcomes and lasting immunity against cancer.

Staffbase is a company that specializes in enhancing employee communication through its comprehensive Communications Cloud platform. The platform is designed for large and international organizations across various sectors, including manufacturing, healthcare, logistics, automotive, retail, and energy. It enables employers to securely engage with their workforce, ensuring that employees have easy access to relevant corporate information and digital workplace tools, including existing intranets. With a focus on mobile compatibility, Staffbase's solutions allow companies to effectively connect with their employees, regardless of their location, whether in the office, at home, or on the factory floor. Serving over 2,500 leading organizations worldwide, Staffbase is dedicated to transforming the way companies communicate with their employees.

Turn.bio is a biotechnology company focused on developing innovative therapies aimed at reversing aging and age-related diseases. Leveraging a patented mRNA platform technology known as ERA, along with a specialized delivery system called eTurna, the company targets the epigenome to restore optimal gene expression. By designing tailored therapies, Turn.bio addresses a range of conditions, including immune-related diseases such as cancer, dermatological issues, and ailments in ophthalmology, osteoarthritis, and the muscular system. The company's approach involves inducing the body to heal itself by instructing specific cells to combat disease and repair damaged tissue, thereby reprogramming cellular functions to enhance health and longevity.

MOQO is a cloud-based platform that provides a comprehensive solution for shared mobility services. The company enables municipal utilities, real estate firms, businesses, and clubs to offer high-quality shared mobility options while benefiting from significant economies of scale. By integrating various services, MOQO facilitates a seamless shared mobility ecosystem, allowing clients to enhance their transportation offerings and improve accessibility for users.

FoxBio is a developer of a small molecules techniques intended to reduce senescent cells in human bodies. The company's techniques targets the pro-survival pathways of senescent cells to remove them from the body, enabling patients to have multiple health benefits and delay the onset of age related diseases.

Staffbase is a company that specializes in enhancing employee communication through its comprehensive Communications Cloud platform. The platform is designed for large and international organizations across various sectors, including manufacturing, healthcare, logistics, automotive, retail, and energy. It enables employers to securely engage with their workforce, ensuring that employees have easy access to relevant corporate information and digital workplace tools, including existing intranets. With a focus on mobile compatibility, Staffbase's solutions allow companies to effectively connect with their employees, regardless of their location, whether in the office, at home, or on the factory floor. Serving over 2,500 leading organizations worldwide, Staffbase is dedicated to transforming the way companies communicate with their employees.

Elevian, Inc. is a biotechnology company based in Menlo Park, California, founded in 2017. The company specializes in developing regenerative medicines aimed at preventing and treating age-related diseases. Elevian focuses on therapeutics that regulate circulating factors, particularly Growth Differentiation Factor 11 (GDF11), which are known to stimulate the regeneration of various tissues, including those in the brain, heart, pancreas, and muscle. By targeting the underlying mechanisms of aging, Elevian aims to halt and potentially reverse the molecular damage associated with aging. Its research and development efforts are directed toward conditions such as stroke recovery, Alzheimer’s disease, coronary artery disease, and Type 2 diabetes.

shyftplan GmbH is a Berlin-based company that specializes in developing software solutions for the human resources industry. Founded in 2012, the company offers a comprehensive SaaS platform focused on employee management and communication. Its core offerings include scheduling, absence management, time tracking, HR management, and payroll services. The platform enables HR managers to efficiently set up and manage shift plans by assigning employees to specific shifts based on their competencies. Additionally, shyftplan enhances workforce management by integrating employee intelligence and facilitating communication between non-desk workers and their work environments. This holistic approach streamlines personnel planning and optimizes operational efficiencies for organizations.

Antoxerene, Inc. is an intellectual property holding company focused on small molecule drug discovery, particularly in relation to aging pathways. Established in 2016 and based in Lafayette, New York, the company operates a unique drug discovery platform that employs patent-pending production technology. This technology facilitates the manufacturing of challenging protein targets in their biologically active forms at scale. Antoxerene aims to identify and develop small molecule drugs that target critical protein-drug and protein-protein interactions, with a particular focus on selectively eliminating toxic senescent cells to restore tissue function. The company actively seeks collaborations with industry and academic partners who share its commitment to advancing next-generation therapies for age-related illnesses.

AgeX Therapeutics, Inc. is a biotechnology company based in Alameda, California, specializing in the development and commercialization of innovative therapeutics aimed at addressing human aging and degenerative diseases. The company harnesses proprietary technologies, including telomerase-mediated cell immortality and induced Tissue Regeneration, to create novel treatments. Its product pipeline features two primary cell-based candidates: AGEX-BAT1, which targets age-related metabolic disorders such as Type II diabetes, and AGEX-VASC1, designed to restore vascular support in ischemic tissues. Additionally, AgeX is working on AGEX-iTR1547, a drug formulation intended to enhance regenerative potential in aged tissues suffering from degenerative conditions. The company also offers human embryonic stem cells and a suite of genomic interpretation tools for researchers. AgeX has collaborated with the University of California, Irvine, on neural stem cell research related to Huntington's disease and other neurological disorders. Founded in 2017, AgeX continues to advance its mission of addressing the challenges associated with aging.

CellAge is a biotechnology company focused on developing innovative tools and therapies aimed at identifying and eliminating aged cells. By leveraging synthetic biology, the company creates advanced methods for targeting senescent cells, which are implicated in various age-related diseases such as osteoarthritis and atherosclerosis. CellAge's mission is to enhance the quality of life for the aging population, enabling individuals to experience their later years with the health and vitality typically associated with youth. Through its research and product development, CellAge aspires to contribute to a future where age-related diseases are significantly diminished, allowing people to enjoy more time with their loved ones.

Lysoclear, Inc. is a biotechnology company based in Lafayette, New York, focused on developing enzyme therapies for eye diseases. Established in 2016, the company aims to create innovative treatments for conditions such as age-related macular degeneration (AMD) and Stargardt’s macular degeneration. Lysoclear is also engaged in developing therapies for lysosomal storage diseases, which arise from defects in endogenous lysosomal enzymes. Currently in the pre-clinical stage, the company's research targets atrophic "dry" AMD and seeks to address significant unmet medical needs in the field of ophthalmology.

MOQO is a cloud-based platform that provides a comprehensive solution for shared mobility services. The company enables municipal utilities, real estate firms, businesses, and clubs to offer high-quality shared mobility options while benefiting from significant economies of scale. By integrating various services, MOQO facilitates a seamless shared mobility ecosystem, allowing clients to enhance their transportation offerings and improve accessibility for users.

Staffbase is a company that specializes in enhancing employee communication through its comprehensive Communications Cloud platform. The platform is designed for large and international organizations across various sectors, including manufacturing, healthcare, logistics, automotive, retail, and energy. It enables employers to securely engage with their workforce, ensuring that employees have easy access to relevant corporate information and digital workplace tools, including existing intranets. With a focus on mobile compatibility, Staffbase's solutions allow companies to effectively connect with their employees, regardless of their location, whether in the office, at home, or on the factory floor. Serving over 2,500 leading organizations worldwide, Staffbase is dedicated to transforming the way companies communicate with their employees.

Ichor Therapeutics, Inc. is a pre-clinical biotechnology company located in Syracuse, NY. The company has several intramural research programs that broadly focus on therapeutic interventions for age-related disease. Ichor is also involved in several smaller ventures aimed at reducing the barriers to entry for biotechnology entrepreneurs and independent scientists.

SuitePad GmbH is a Berlin-based company specializing in tablet-based communication solutions for the hospitality industry. Founded in 2012, the company aims to enhance the guest experience by integrating various services into a single device. Its tablets serve as a comprehensive platform for hotel guests, providing essential information about the hotel and its surroundings, while facilitating direct bookings for services such as room service and wellness appointments. SuitePad has successfully collaborated with both private and chain hotels across Germany, Austria, and Switzerland to ensure its product meets the specific needs of its clients. Since its first installation in 2013, SuitePad has expanded its presence to 11 European countries and has received multiple industry awards, including the CeBit BITKOM Innovation Award and the HSMAI Technology and Innovation Award, for its innovative contributions to hotel guest communication.

Mambu is a SaaS (Software as a Service) company that develops a cloud-based core banking platform. It enables financial institutions, including banks, fintech startups, and microfinance institutions, to manage credit and deposit products more efficiently. Mambu's platform simplifies credit risk assessment, loan lifecycle tracking, and portfolio management. It also streamlines internal workflows, improves data quality, and reduces fraud risk. With a presence in multiple countries, Mambu serves over 200 clients globally, helping them build modern digital financial products faster, securely, and cost-effectively.

Staffbase is a company that specializes in enhancing employee communication through its comprehensive Communications Cloud platform. The platform is designed for large and international organizations across various sectors, including manufacturing, healthcare, logistics, automotive, retail, and energy. It enables employers to securely engage with their workforce, ensuring that employees have easy access to relevant corporate information and digital workplace tools, including existing intranets. With a focus on mobile compatibility, Staffbase's solutions allow companies to effectively connect with their employees, regardless of their location, whether in the office, at home, or on the factory floor. Serving over 2,500 leading organizations worldwide, Staffbase is dedicated to transforming the way companies communicate with their employees.

Prescreen International, established in 2011 and headquartered in Munich, Germany, specializes in developing and operating a cloud-based e-recruitment platform and applicant tracking system. The company streamlines recruitment processes by enabling businesses to publish job vacancies online and offline, collect applications, analyze data, and evaluate candidates efficiently. As of 2017, Prescreen operates as a subsidiary of XING AG.

Oisin Biotechnologies, Inc. is a biotechnology company based in Seattle, Washington, established in 2014, that specializes in developing therapies aimed at addressing age-related diseases through the elimination of senescent cells. The company utilizes a proprietary technology platform known as SENSOlytics, which enables the precise targeting of senescent cells based on their DNA expression, distinguishing them from healthy cells. Oisin Biotechnologies is advancing a range of interventions, including a lead program that targets frailty by promoting muscle growth independent of exercise and another that selectively eliminates fat cells. The company's innovative approach employs a non-viral delivery system, facilitating the effective distribution of DNA and RNA-based therapies to combat various age-related conditions. Research indicates that the clearance of senescent cells not only mitigates the adverse effects of aging but may also extend lifespan and enhance overall health.

shyftplan GmbH is a Berlin-based company that specializes in developing software solutions for the human resources industry. Founded in 2012, the company offers a comprehensive SaaS platform focused on employee management and communication. Its core offerings include scheduling, absence management, time tracking, HR management, and payroll services. The platform enables HR managers to efficiently set up and manage shift plans by assigning employees to specific shifts based on their competencies. Additionally, shyftplan enhances workforce management by integrating employee intelligence and facilitating communication between non-desk workers and their work environments. This holistic approach streamlines personnel planning and optimizes operational efficiencies for organizations.

Mambu is a SaaS (Software as a Service) company that develops a cloud-based core banking platform. It enables financial institutions, including banks, fintech startups, and microfinance institutions, to manage credit and deposit products more efficiently. Mambu's platform simplifies credit risk assessment, loan lifecycle tracking, and portfolio management. It also streamlines internal workflows, improves data quality, and reduces fraud risk. With a presence in multiple countries, Mambu serves over 200 clients globally, helping them build modern digital financial products faster, securely, and cost-effectively.

SuitePad GmbH is a Berlin-based company specializing in tablet-based communication solutions for the hospitality industry. Founded in 2012, the company aims to enhance the guest experience by integrating various services into a single device. Its tablets serve as a comprehensive platform for hotel guests, providing essential information about the hotel and its surroundings, while facilitating direct bookings for services such as room service and wellness appointments. SuitePad has successfully collaborated with both private and chain hotels across Germany, Austria, and Switzerland to ensure its product meets the specific needs of its clients. Since its first installation in 2013, SuitePad has expanded its presence to 11 European countries and has received multiple industry awards, including the CeBit BITKOM Innovation Award and the HSMAI Technology and Innovation Award, for its innovative contributions to hotel guest communication.

Babbel is a leading online language learning platform that offers interactive, real-world language courses. It provides over 60,000 lessons across 14 languages, crafted by linguists and tailored to users' progress. Babbel's ecosystem includes the Babbel App, live online classes with native teachers, podcasts, and a business-focused product. The company's approach, backed by linguistic research, enables users to learn and speak new languages effectively. With a diverse team of over 1,000 employees across two continents, Babbel has sold over 16 million subscriptions, fostering mutual understanding through language learning.

Mambu is a SaaS (Software as a Service) company that develops a cloud-based core banking platform. It enables financial institutions, including banks, fintech startups, and microfinance institutions, to manage credit and deposit products more efficiently. Mambu's platform simplifies credit risk assessment, loan lifecycle tracking, and portfolio management. It also streamlines internal workflows, improves data quality, and reduces fraud risk. With a presence in multiple countries, Mambu serves over 200 clients globally, helping them build modern digital financial products faster, securely, and cost-effectively.

Hipaway operates an online platform facilitating hotel bookings exclusively within Germany.

Hojoki is a team collaboration application that integrates various cloud services to streamline workflow and communication. It enables users to consolidate notifications from multiple platforms, allowing for real-time discussion and updates related to ongoing projects. The application supports a wide range of cloud tools, including Google Docs, Dropbox, Evernote, and GitHub, among others. By bringing together these disparate applications, Hojoki enhances productivity and facilitates seamless teamwork.

Hojoki is a team collaboration application that integrates various cloud services to streamline workflow and communication. It enables users to consolidate notifications from multiple platforms, allowing for real-time discussion and updates related to ongoing projects. The application supports a wide range of cloud tools, including Google Docs, Dropbox, Evernote, and GitHub, among others. By bringing together these disparate applications, Hojoki enhances productivity and facilitates seamless teamwork.

Tamyca GmbH is a mobility platform provider that operates a leading peer-to-peer carsharing marketplace in Germany, known as Tamyca - take my car, which launched in November 2010. The platform enables car owners to list their idle vehicles for rent, allowing them to earn extra income by setting their own prices and availability. Users seeking access to a vehicle can conveniently find options in their neighborhood through a smartphone app or web service, achieving cost savings of up to 60% compared to traditional car rental and carsharing services. Tamyca also offers additional solutions based on onboard systems, booking software, and operational support, enhancing the overall user experience in the car-sharing ecosystem.

Pactas provides a SaaS platform for recurring billing and subscription management for SaaS and subscription companies, no matter you are a startup or a well established business. Follow us: @pactashq on Twitter | pactas on Facebook

Advertory GmbH, established in Berlin, Germany, in 2010 by a German-French team, specializes in providing an online marketing platform tailored for small and mid-sized businesses. The company offers user-friendly tools to create and maintain an effective web presence, integrated with local search offerings and mobile versions to attract new customers. Their primary clientele includes freelancers, service providers, craftsmen, and restaurants. Advertory's platform aims to help these businesses compete online, monitor performance, and retain customers efficiently, even with limited time for website management.

MegaZebra GmbH is a Munich-based developer and publisher of casual online games, established in 2008. The company specializes in creating engaging games for social network communities worldwide, with titles such as Solitaire Castle, Mahjong Trails, Mahjong, Nuzzle Puzzle, and Sudoku. MegaZebra's games are designed to be playable across various platforms, allowing users to connect and play with friends and family on social networks, including integration with Facebook. The company is backed by a seasoned team of professionals, enhancing its capabilities in the competitive online gaming market.

Mambu is a SaaS (Software as a Service) company that develops a cloud-based core banking platform. It enables financial institutions, including banks, fintech startups, and microfinance institutions, to manage credit and deposit products more efficiently. Mambu's platform simplifies credit risk assessment, loan lifecycle tracking, and portfolio management. It also streamlines internal workflows, improves data quality, and reduces fraud risk. With a presence in multiple countries, Mambu serves over 200 clients globally, helping them build modern digital financial products faster, securely, and cost-effectively.

MegaZebra GmbH is a Munich-based developer and publisher of casual online games, established in 2008. The company specializes in creating engaging games for social network communities worldwide, with titles such as Solitaire Castle, Mahjong Trails, Mahjong, Nuzzle Puzzle, and Sudoku. MegaZebra's games are designed to be playable across various platforms, allowing users to connect and play with friends and family on social networks, including integration with Facebook. The company is backed by a seasoned team of professionals, enhancing its capabilities in the competitive online gaming market.

Babbel is a leading online language learning platform that offers interactive, real-world language courses. It provides over 60,000 lessons across 14 languages, crafted by linguists and tailored to users' progress. Babbel's ecosystem includes the Babbel App, live online classes with native teachers, podcasts, and a business-focused product. The company's approach, backed by linguistic research, enables users to learn and speak new languages effectively. With a diverse team of over 1,000 employees across two continents, Babbel has sold over 16 million subscriptions, fostering mutual understanding through language learning.